TransCode Therapeutics Inc (NASDAQ: RNAZ) is -69.73% lower on its value in year-to-date trading and has touched a low of $1.10 and a high of $66.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RNAZ stock was last observed hovering at around $1.12 in the last trading session, with the day’s loss setting it -0.1%.
Currently trading at $1.02, the stock is -79.82% and -81.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.36 million and changing -8.93% at the moment leaves the stock -93.40% off its SMA200. RNAZ registered -95.58% loss for a year compared to 6-month gain of -87.91%.
The stock witnessed a -91.36% loss in the last 1 month and extending the period to 3 months gives it a -86.80%, and is -44.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.50% over the week and 21.83% over the month.
TransCode Therapeutics Inc (RNAZ) has around 10 employees, a market worth around $0.71M and $0.00M in sales. Distance from 52-week low is -7.27% and -98.46% from its 52-week high. The company has generated returns on investments over the last 12 months (-903.45%).
with sales reaching $300k over the same period.The EPS is expected to grow by 95.41% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 0.70M, and float is at 0.66M with Short Float at 81.96%.
